Vaccines using mRNA are currently being studied for a wide range of diseases, including cancer, cardiovascular disease, ...

The concept of turning a cell’s final act into a therapeutic trigger is bold—and it’s gaining traction. Future treatments could include vaccines ... within the journal Cancer Discovery.

The type of kidney cancer they had - stages three and four clear cell renal cell ... immune response with the vaccine.’ Their findings were published in the journal Nature.

Finally, Mendus unveiled new data from its phase 1 ALISON trial of vididencel (DCP-001) – an off-the-shelf allogeneic dendritic cell-based vaccine – in high-grade serous ovarian cancer (HGSOC ...

All nine patients in a Phase I investigator-led trial of a personalised kidney cancer vaccine ... cell carcinoma (ccRCC) following tumour removal surgery. Results published this week in the ...

The work has been published in the journal Cellular & Molecular Immunology. Researchers have been working for 15 years to improve cancer vaccines ... down the foreign cell components into ...

Forget one-size-fits-all cancer treatments — personalization is the future, and it’s already showing promise. In a groundbreaking early-phase trial, a personalized vaccine triggered a powerful ...